Quality of Life and Depression in Patients with and without Idiopathic Parkinson’s Disease without Dementia.
Objective: To identify the impact of depression on QoL in a group of patients with IPDWD. Background: The Quality of Life (QoL) in patients with…Critical appraisal of MDS Criteria for diagnosing PD
Objective: To determine the validity of MDS Diagnostic criteria for PD by assessing individual diagnostic criteria in pathologically confirmed PD Background: The 2015 MDS criteria…Parkinson’s disease overlapping with other neurodegeneration-case series with neuropathological description.
Objective: The aim of the study is to report Parkinson’s disease (PD) case series with co-occurening amyotrophic lateral sclerosis (ALS) and neuropathologically characterize one case.…The Relationship Between Demographic and Clinical Characteristics with Disease Severity and Quality of Life in Parkinson’s Patients
Objective: To examine the relationship between demographic and clinical characteristics with Parkinson’s disease severity and quality of life, measured using the Hoehn & Yahr (H&Y)…Prevalence and Clinical Characteristics of Parkinson’s disease in Rural Nepal: A Community-Based Cross-Sectional Study
Objective: This study aims to determine the prevalence of PD in rural Nepal and characterize its clinical features in an effort to bridge the gap…Clinical analysis of sarcopenia prevalence and its influencing factors in patients with Parkinson’s disease
Objective: In this study, we examined the prevalence of sarcopenia in patients with Parkinson's disease (PD) and the factors affecting sarcopenia in patients with PD,…Center of Mass and Center of Pressure interactions during Gait in people with Parkinson’s Disease
Objective: To compare lateral stability during gait in people with Parkinson’s Disease (PD), compared to healthy controls (HC). Background: PD is a progressive neurodegenerative disorder[1],…People With Parkinson’s Disease and Care Partners Experience Costly Work Productivity Loss
Objective: To evaluate work productivity loss (WPL) and associated costs among people with newly diagnosed Parkinson’s Disease (nPD), advanced PD (aPD), and care partners (CP).…Clinical Manifestations and Rate of Progression of Parkinsons Disease in Different Regions
Objective: To determine the differences in the age of onset of clinical manifestations and rate of progression of Parkinson's disease in different regions of Tajikistan.…Metabolomic Profiling in an Egyptian Cohort Reveals Altered Phenylalanine Metabolism and Suggests a Role for Trans-Cinnamate in Parkinson Disease
Objective: Investigate the associated metabolic changes in PD via a comprehensive metabolic analysis with a focus on phenylalanine (dopamine precursor) metabolism and its impact on…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 436
- Next Page »